ESR1 and breast carcinoma: A quite impressive number of studies from several labs comprising ours have reported Estrogen Receptor α (ERα, ESR1) genomic binding, ERα-controlled transcriptomes and biological effects of agonists and antagonists in human breast cancer cells13, 14.